For the preparation of ALC-0315-containing LNPs
Features
  • Conveniently packaged reagents for preparing LNPs
  • Included in the kit: ALC-0315, 1,2-DSPC, cholesterol, and ALC-0159
  • May be used for the encapsulation of mRNA or siRNA cargo
  • Adaptable protocols suited for a range of specialized-to-basic equipment
  • Formerly known as our Lipid Nanoparticle (LNP-0315) Exploration Kit
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LipidLaunch™ LNP-0315 Exploration Kit

Item No. 35426

Kit Booklet (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Lipid Nanoparticle (LNP-0315) Exploration Kit
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    1 ea

    $319

    Add
    Cayman Chemical
    Product Description

    This kit, formerly known as Lipid Nanoparticle (LNP-0315) Exploration Kit, has recently been renamed to join our line of research-ready LipidLaunch™ products for LNP applications. Cayman’s LipidLaunch™ LNP-0315 Exploration Kit is intended to serve as a starting point for laboratories to explore the feasibility of using LNPs for their individual application without the need for specialized equipment. Optimal preparation conditions for the encapsulation of nucleic acids with LNPs must be determined by the end user.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Citations

    Ott, A.C., Loll, P.J., and Burns, J.M., Jr. An mRNA vaccine expressing blood-stage malaria antigens induces complete protection against lethal Plasmodium yoelii. Vaccines (Basel) 13(7), 702 (2025).

    Coates, I.A., Driskill, M.M., Rajesh, N.U., et al. Free-Form Microfluidic Microneedle Array Patches. Adv. Funct. Mater. e14879 (2025).